|
Rivera-Caravaca JM, Roldan V, Vicente V, Lip GYH, Marin F. Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation. Mayo Clin Proc. 2020 Nov;95(11):2360-2369. doi: 10.1016/j.mayocp.2020.05.046. PubMed PMID: 33153628.
AÑO: 2020; IF: 11.104
|
33153628
|
Rivera-Caravaca JM, Vilchez JA, Rodriguez-Rojas C, Albadalejo-Oton MD, Gil-Perez P, Lopez-Garcia C, Veliz-Martinez A, Roldan V, Marin F. Influence of the matrix type over the concentration of GDF-15. J Investig Med. 2020 Dec;68(8):1402-1404. doi: 10.1136/jim-2020-001351. Epub 2020 Sep 8. PubMed PMID: 32907909.
AÑO: 2020; IF: 2.895
|
|
Rivera-Caravaca JM, Gil-Perez P, Lopez-Garcia C, Veliz-Martinez A, Quintana-Giner M, Romero-Aniorte AI, Fernandez-Redondo C, Munoz L, Quero E, Esteve-Pastor MA, Lip GYH, Roldan V, Marin F. A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes. Int J Clin Pract. 2020 Dec;74(12):e13634. doi: 10.1111/ijcp.13634. Epub 2020 Aug 25. PubMed PMID: 32745337.
AÑO: 2020; IF: 2.503
|
|
Rivera-Caravaca JM, Esteve-Pastor MA, Camelo-Castillo A, Ramirez-Macias I, Lip GYH, Roldan V, Marin F. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert Opin Pharmacother. 2020 Oct;21(15):1867-1881. doi: 10.1080/14656566.2020.1789099. Epub 2020 Jul 13. PubMed PMID: 32658596.
AÑO: 2020; IF: 3.889
|
|
Camelo-Castillo A, Rivera-Caravaca JM, Marin F, Vicente V, Lip GYH, Roldan V. Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project. Thromb Haemost. 2020 Aug;120(8):1200-1207. doi: 10.1055/s-0040-1712914. Epub 2020 Jun 7. PubMed PMID: 32506417.
AÑO: 2020; IF: 6.681
|